Semax Near Me: 10 Units Is 500 mcg and Costs $1.50

Four kinds of result come back from this query, and none of them is a local Semax supplier in the sense the search implies.

The last row is where the search realistically ends, and it is not local in any meaningful sense. It is a parcel. The proximity in a nearby result is usually proximity of the business to you rather than proximity of the product to the business, and the distinction is worth holding onto because the first one costs you nothing and the second one is what you were actually looking for.

This site does not publish clinic names or locations for this compound, and no page honestly can, because there is no verified local channel to list. Anywhere you see one invented, treat the rest of the page the same way.

Of the four rows above, one is not a matter of stocking decisions. A 503A compounding pharmacy needs the bulk substance to be eligible before it can compound with it, and Semax is not on the section 503A bulks list.

The history is worth stating precisely because it is garbled everywhere. Semax was nominated for the list. It was placed in category 2 under FDA's interim policies while the agency evaluated it. The nomination was then withdrawn by the nominator, and today Semax appears on FDA's list of bulk drug substances nominated but withdrawn, in none of the three current categories, with no FDA approval for any indication. Being on no list is not a ban and not a clearance; it means the evaluation stopped before it concluded.

FDA's recorded concern also explains what to look for if you buy anyway. Compounded drugs containing semax (heptapeptide) may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities, and the agency writes that it lacks sufficient information to know whether the drug would cause harm if administered to humans. Aggregation and impurities are measurable. Whether anybody measured them is a question about a certificate, not about a location.

Selank is in exactly the same position for the same reason, covered on our Selank near me page. The instructive contrast is NAD+, where a genuine clinic channel does exist and the local search returns real answers, which turns the whole question into one about price rather than availability. Our NAD+ near me page runs that comparison, and it is the reason the two searches feel similar and behave nothing alike.

The number that makes a local offer assessable is the material rate, and on this listing it is fixed and public. These are laboratory handling figures for research material and not dosing guidance.

The middle column depends on a choice and the money columns do not, which is the point most local comparisons miss. Reconstitute the same vial at 1 mL and it is 10 mg/mL, so 500 mcg is five units instead of ten; at 5 mL it is 2 mg/mL and the same 500 mcg is twenty-five units. The unit count changes, the price does not, because units measure volume and money follows mass. Our syringe measurement guide covers reading the barrel and the Semax calculator will run any volume.

One refinement on the batch that was weighed. Kovera Labs reported a net content of 11.23 mg for batch 30-05260628 rather than the labelled 10 mg, which makes the true material rate $2.67 a milligram on that batch and turns 2 mL into 5.615 mg/mL rather than 5 mg/mL. Ten units then carries 562 mcg, not 500. The label figure is what the listing promises; the weighed figure belongs to one batch.

Local offers are quoted in whatever unit suits the seller, which is usually not milligrams. Three conversions cover almost everything you will meet. The figures below are worked examples chosen to show the method, not prices anyone has quoted us.

Two of those four rows end in the same place, which is the honest finding. A quote that cannot be reduced to a mass cannot be compared to $3.00 a milligram, and a seller who will not supply the mass has effectively declined to give you a price. That is not a trick question or an unreasonable demand; every legitimate research listing states a mass on the label because the certificate is written against one.

When the conversion does complete, the arithmetic is usually decisive rather than close. The worked examples above land at two and a half to four times the vial rate, and that spread is typical of what formulation, filling and a local premium cost. Some of that is worth paying for. All of it should be visible before you decide, and our MOTS-c near me page runs the same conversion on a compound where the local search returns even less.

If a local seller genuinely has it, the questions are the same ones you would ask an online storefront, and the fact of proximity answers none of them. Being able to drive to a business tells you where it is, not what is in the vial.

• A batch number on the vial that matches a certificate you can open. Not a certificate for the product line. For that batch. A mismatch here is the most common failure in the whole category, and it is checkable in seconds.
• Purity stated against a specification. A bare percentage is not assessable. Batch 30-05260628 reports 99.886% against a specification of greater than 98%, which is the shape the line should take.
• Identity confirmed, not assumed. Purity says how much of the powder is one substance. Mass spectrometry says which substance. Semax and Selank are both Russian heptapeptides sold from the same shelves and are routinely confused, so identity is not a formality here.
• An endotoxin figure with the volume it was measured across. Endotoxin is a concentration. Under 0.20 EU/mL measured across 2.0 mL is under 0.40 units in the vial, which stays inside the 0.5 EU/mL acceptance limit at any reconstitution volume of 1 mL or more. A figure quoted without a volume is not a figure.
• A stated price per milligram. If they will not divide, do it yourself, and if there is nothing to divide by, walk.

Two limits, so nothing here reads as reassurance. The sterility result on this batch is a rapid screen and the report says so on its own face, noting that full USP Chapter 71 sterility testing may be required for regulatory compliance. And every number above belongs to one batch, which is evidence about that batch and not a safety finding about a compound FDA says it lacks adequate human data on. A well documented unapproved compound is still unapproved, whether it reaches you by parcel or from down the road.